The Mathers Foundation, a highly selective national funder of innovative basic biomedical research, is supporting Thaxton’s work on a discovery that has the potential to transform human health.

Researchers will develop and implement new strategies to address common barriers to care and reach patients due for cancer screenings for breast, colorectal, lung, and/or cervical cancers.

Researchers are investigating a new way to tackle bone cancer while minimizing toxicity typically associated with chemotherapy.

Backed by results from the OPTIMA trial, the Prosigna Breast Risk of Recurrence (ROR) test offers a new way to personalize treatment and reduce unnecessary chemotherapy for patients with breast cancer.

How a cancer is first discovered can shape what happens next, and new research shows that steps are needed to map out treatment for older adults diagnosed in the emergency department who face sharply lower survival.

Researchers conduct new patient registry and radiation therapy study to improve outcomes for patients at high risk of liver cancer and those with early-stage cancer, respectfully

UNC School of Medicine’s Melissa Troester, PhD, MPH, named among group of cutting-edge researchers to receive funding to fuel breakthroughs in breast cancer care.

Researchers mailed the test to recipients across North Carolina and calculated a nearly 20% increase among residents who agreed to take the test, regardless of race or ethnicity.

The genetic tool allows doctors to better tailor treatments to each patient's unique subtype of B-cell acute lymphoblastic leukemia.

The new study, led by researchers in the lab of Blossom Damania, PhD, has identified a new therapeutic target for difficult-to-treat cases of non-Hodgkin lymphoma

The newly developed cells address a significant limitation present in existing treatment approaches and may offer a promising solution for acute myeloid leukemia.

Celebrating its 25th anniversary, the Rex Mobile Mammography, a department of UNC Health Rex Hospital, will welcome a new mobile mammography unit this year named Hope Esperanza, or “Hope.”

Tag: UNC Lineberger Comprehensive Cancer Center

Thaxton Awarded Prestigious Grant for T-Cell Metabolism Research

UNC Lineberger and OHSU Receive $4 Million to Address Barriers to Cancer Screening Across North Carolina, Oregon

UNC Biochemists Discover New Method to Combat Pediatric Bone Cancer

Hormone Therapy or Chemotherapy? A Test Developed by a UNC Researcher Can Tell You

New Research from UNC Lineberger Comprehensive Cancer Center Links Emergency Cancer Diagnoses to Significantly Lower Survival

UNC Lineberger Researchers Advance Early-Stage Liver Cancer Detection and Treatments

Troester Receives Leadership Grant from Susan G. Komen

UNC Study Shows Strong Patient Response to At-Home Colorectal Cancer Screening

UNC Researchers Develop Faster, Low-Cost Method to Diagnose Common Pediatric Cancer

UNC Study Reveals Promising New Therapy for Non-Hodgkin Lymphoma

UNC Researchers Create More Effective, Less Toxic Immunotherapy to Combat Blood Cancer

Traveling with Hope: Rex Mobile Mammography Celebrates 25 Years of Service